Stereotactic Radiotherapy of Primary Lung Cancer and Other Targets: Results of Consultant Meeting of the International Atomic Energy Agency
- Hiroshima University Hospital, Department of Radiation Oncology, Hiroshima (Japan)
- Institut of Radiation Oncology, Lindenhospital, Bern (Switzerland)
- Division of Oncology and Hospital Physics, Radiumhemmet, Karolinska University Hospital (Sweden)
- Department of Radiation Oncology, The University of Texas Southwestern Medical Center, Dallas (United States)
- Department of Radiation Oncology, University Hospital, University Basel, Basel (Switzerland)
- International Atomic Energy Agency, Vienna (Austria)
To evaluate the current status of stereotactic body radiotherapy (SBRT) and identify both advantages and disadvantages of its use in developing countries, a meeting composed of consultants of the International Atomic Energy Agency was held in Vienna in November 2006. Owing to continuous developments in the field, the meeting was extended by subsequent discussions and correspondence (2007-2010), which led to the summary presented here. The advantages and disadvantages of SBRT expected to be encountered in developing countries were identified. The definitions, typical treatment courses, and clinical results were presented. Thereafter, minimal methodology/technology requirements for SBRT were evaluated. Finally, characteristics of SBRT for developing countries were recommended. Patients for SBRT should be carefully selected, because single high-dose radiotherapy may cause serious complications in some serial organs at risk. Clinical experiences have been reported in some populations of lung cancer, lung oligometastases, liver cancer, pancreas cancer, and kidney cancer. Despite the disadvantages expected to be experienced in developing countries, SBRT using fewer fractions may be useful in selected patients with various extracranial cancers with favorable outcome and low toxicity.
- OSTI ID:
- 21491620
- Journal Information:
- International Journal of Radiation Oncology, Biology and Physics, Vol. 79, Issue 3; Other Information: DOI: 10.1016/j.ijrobp.2010.10.004; PII: S0360-3016(10)03377-8; Copyright (c) 2011 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; ISSN 0360-3016
- Country of Publication:
- United States
- Language:
- English
Similar Records
Radiosensitivity Differences Between Liver Metastases Based on Primary Histology Suggest Implications for Clinical Outcomes After Stereotactic Body Radiation Therapy
Stereotactic Body Radiotherapy for Oligometastatic Lung Tumors
Related Subjects
CONSULTANTS
DEVELOPING COUNTRIES
IAEA
KIDNEYS
LIVER
LUNGS
MEETINGS
NEOPLASMS
PANCREAS
RADIOTHERAPY
RECOMMENDATIONS
BODY
DIGESTIVE SYSTEM
DISEASES
ENDOCRINE GLANDS
GLANDS
INTERNATIONAL ORGANIZATIONS
MEDICINE
NUCLEAR MEDICINE
ORGANS
PERSONNEL
RADIOLOGY
RESPIRATORY SYSTEM
THERAPY